Risk stratification and medical therapy of pulmonary arterial hypertension
Open accessThe DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Abstract
Pulmonary arterial hypertension (PAH) remains a severe clinical condition despite the availability over the past 15 years of multiple drugs interfering with the endothelin, nitric oxide and prostacyclin pathways. The recent progress observed in medical therapy of PAH is not, therefore, related to the discovery of new pathways, but to the development of new strategies for combination therapy and on escalation of treatments based on systematic assessment of clinical response. The current treatment strategy is based on the severity of the newly diagnosed PAH patient as assessed by a multiparametric risk stratification approach. Clinical, exercise, right ventricular function and haemodynamic parameters are combined to define a low-, intermediate- or high-risk status according to the expected 1-year mortality. The current treatment algorithm provides the most appropriate initial strategy, including monotherapy, or double or triple combination therapy. Further treatment escalation is required in case low-risk status is not achieved in planned follow-up assessments. Lung transplantation may be required in most advanced cases on maximal medical therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![FIGURE 1 Time-course of completed randomised controlled trials (RCTs) in pulmonary arterial hypertension (PAH) (n=41) according to treatment strategy. SSc: systemic sclerosis; IPAH: idiopathic PAH. Reproduced and modified from [70] with permission.](https://figures.cochat.ai/paper-figures/44281cb9913845f29b53a42c8e3258e5/risk-stratification-and-medical-therapy-of-pulmonary-arterial-hypertension-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other high-risk profiles include familial PAH, PVOD, CTD-PAH, CTD-PAH associated with concomitant ILD, rapidly progressive disease despite therapy, and development of hemoptysis.(282, 291–293)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In particular, the 2018 World Symposium on Pulmonary Hypertension strongly recommends serial parametric risk assessment.(282)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
The cited source says what the claim attributes to it.
In the citing paper
“The 2018 World Symposium on Pulmonary Hypertension states that the ultimate goal of therapy for patients with PAH is to achieve a low-risk status, assessed either by REVEAL or the ESC/ERS model.(282)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [282]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv317 · Cited by 6,931
Self-citationHaemodynamic definitions and updated clinical classification of pulmonary hypertension
Simonneau, G., Montani, D., Celermajer, D. S., Denton, C. P., Gatzoulis, M. A., Krowka, M., Williams, P. G., & Souza, R. (2019) · European Respiratory Journal · doi:10.1183/13993003.01913-2018 · Cited by 3,813
D'Alonzo, G. E., Barst, R. J., Ayres, S. M., Bergofsky, E. H., Brundage, B. H., Detre, K. M., Fishman, A. P., Goldring, R. M., Groves, B. M., Kernis, J. T., et al. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-5-343 · Cited by 3,501
Galiè, N., Humbert, M., Vachiery, J.-L., Gibbs, S., Lang, I., Torbicki, A., Simonneau, G., Peacock, A., Vonk Noordegraaf, A., Beghetti, M., et al. (2015) · European Respiratory Journal · doi:10.1183/13993003.01032-2015 · Cited by 3,172
Self-citationBosentan Therapy for Pulmonary Arterial Hypertension
Rubin, L. J., Badesch, D. B., Barst, R. J., Galiè, N., Black, C. M., Keogh, A., Pulido, T., Frost, A., Roux, S., Leconte, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012212 · Cited by 2,726
Self-citationBarst, R. J., Rubin, L. J., Long, W. A., McGoon, M. D., Rich, S., Badesch, D. B., Groves, B. M., Tapson, V. F., Bourge, R. C., Brundage, B. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602013340504 · Cited by 2,698
Sildenafil Citrate Therapy for Pulmonary Arterial Hypertension
Galiè, N., Ghofrani, H. A., Torbicki, A., Barst, R. J., Rubin, L. J., Badesch, D., Fleming, T., Parpia, T., Burgess, G., Branzi, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050010 · Cited by 2,476
Self-citationInhaled Iloprost for Severe Pulmonary Hypertension
Olschewski, H., Simonneau, G., Galiè, N., Higenbottam, T., Naeije, R., Rubin, L. J., Nikkho, S., Speich, R., Hoeper, M. M., Behr, J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020204 · Cited by 1,783
Self-citationBenza, R. L., Miller, D. P., Gomberg-Maitland, M., Frantz, R. P., Foreman, A. J., Coffey, C. S., Frost, A., Barst, R. J., Badesch, D. B., Elliott, C. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898122 · Cited by 1,547
Self-citationChannick, R. N., Simonneau, G., Sitbon, O., Robbins, I. M., Frost, A., Tapson, V. F., Badesch, D. B., Roux, S., Rainisio, M., Bodin, F., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06250-x · Cited by 1,534
Self-citation
Research works printed but not linked: 2
- Benza, 2018, Comparison of three assessment strategies as predictors of one-year survival in US pulmonary arterial hypertension (PAH) patients, Am J Respir Crit Care Med, 197, A7649
- Galiè, 2014, AMBITION: a randomised, multicenter study of first-line ambrisentan and tadalafil combination therapy in subjects with pulmonary arterial hypertension (PAH), Eur Respir J, 44, 2916
Cited by
Items 101–200 of 897
Management of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis
Almaaitah, S., Highland, K. B., & Tonelli, A. R. (2020) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s232038 · Cited by 46
Relationship Between Time From Diagnosis and Morbidity/Mortality in Pulmonary Arterial Hypertension
Gaine, S., Sitbon, O., Channick, R. N., Chin, K., Sauter, R., Galiè, N., Hoeper, M. M., McLaughlin, V. V., Preiss, R., Rubin, L. J., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.01.066 · Cited by 45
Self-citationBernal‐Ramírez, J., Díaz‐Vesga, M. C., Talamilla, M., Méndez, A., Quiroga, C., Garza-Cervantes, J. A., Lázaro‐Alfaro, A., Jerjes-Sánchez, C., Henríquez, M., García‐Rivas, G., et al. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9993060 · Cited by 44
D’Alto, M., Badagliacca, R., Giudice, F. L., Argiento, P., Casu, G., Corda, M., Correale, M., Ghio, S., Greco, A., Lattanzio, M., et al. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2020.08.016 · Cited by 44
Treatment of pulmonary hypertension associated with COPD: a systematic review
Arif, R., Pandey, A. K., Zhao, Y., Arsenault‐Mehta, K., Khoujah, D., & Mehta, S. (2021) · ERJ Open Research · doi:10.1183/23120541.00348-2021 · Cited by 44
Nathan, S. D., Deng, C., King, C. S., DuBrock, H. M., Elwing, J., Rajagopal, S., Rischard, F. P., Sahay, S., Broderick, M. J., Shen, E., et al. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.09.007 · Cited by 44
Shah, N. B., Mitchell, R. E., Proctor, S. T., Choi, L., DeClercq, J., Jolly, J. A., Hemnes, A. R., & Zuckerman, A. D. (2019) · PLoS ONE · doi:10.1371/journal.pone.0217798 · Cited by 43
Mondéjar‐Parreño, G., Cogolludo, A. L., & Pérez‐Vizcaíno, F. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107835 · Cited by 43
Vicenzi, M., Caravita, S., Rota, I., Casella, R., Deboeck, G., Beretta, L., Lombi, A., & Vachiéry, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265059 · Cited by 43
Khirfan, G., Melillo, C. A., Abdi, S. A., Lane, J. E., Dweik, R. A., Chatburn, R. L., Hatipoglu, U. S., & Tonelli, A. R. (2022) · CHEST Journal · doi:10.1016/j.chest.2022.04.002 · Cited by 42
Ploegstra, M., Ivy, D. D., Beghetti, M., Bonnet, D., Alehan, D., Ablonczy, L., Mattos, S. D. S., Bowers, D., Humpl, T., Berger, R. M. F., et al. (2023) · European Heart Journal - Quality of Care and Clinical Outcomes · doi:10.1093/ehjqcco/qcad020 · Cited by 42
Self-citationAnderson, J., Lau, E., Lavender, M. A., Benza, R. L., Celermajer, D. S., Collins, N. J., Corrigan, C., Dwyer, N., Feenstra, J., Horrigan, M., et al. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.08.2203 · Cited by 41
Galiè, N., Gaine, S., Channick, R. N., Coghlan, G., Hoeper, M. M., Lang, I. M., McLaughlin, V. V., Lassen, C., Rubin, L. J., Schmitz, S. H., et al. (2021) · Advances in Therapy · doi:10.1007/s12325-021-01898-1 · Cited by 41
Self-citationImpact of race on survival in pulmonary arterial hypertension: Results from the REVEAL registry
Medrek, S. K., Sahay, S., Zhao, C., Selej, M., & Frost, A. (2020) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.11.024 · Cited by 40
Riociguat: Clinical research and evolving role in therapy
Klinger, J. R., Chakinala, M. M., Langleben, D., Rosenkranz, S., & Sitbon, O. (2020) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14676 · Cited by 40
Pulmonary hypertension mortality trends in United States 1999–2019
Kang, M., Hart, C. M., Kempker, J. A., Veeraraghavan, S., & Trammell, A. W. (2022) · Annals of Epidemiology · doi:10.1016/j.annepidem.2022.09.001 · Cited by 40
Lung Transplantation for Pulmonary Arterial Hypertension
Kolaitis, N. A. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.04.047 · Cited by 40
Mitochondrial dysfunction in pulmonary arterial hypertension
Zhang, W., Liu, B., Wang, Y., Zhang, H., He, L., Wang, P., & Dong, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1079989 · Cited by 38
Intravenous treprostinil as an add-on therapy in patients with pulmonary arterial hypertension
Olsson, K. M., Richter, M. J., Kamp, J. C., Gall, H. J., Heine, A., Ghofrani, H. A., Fuge, J., Ewert, R., & Hoeper, M. M. (2019) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2019.05.002 · Cited by 38
Pulmonary veno-occlusive disease: illustrative cases and literature review
Lechartier, B., Boucly, A., Solinas, S., Gopalan, D., Dorfmüller, P., Radonic, T., Sitbon, O., & Montani, D. (2024) · European Respiratory Review · doi:10.1183/16000617.0156-2023 · Cited by 37
Vázquez‐Garza, E., Bernal‐Ramírez, J., Jerjes-Sánchez, C., Lozano, O., Acuna-Morin, E. E., Tamez, M. V., Ramos-González, M. R., Chapoy‐Villanueva, H., Pérez-Plata, L., Sánchez-Trujillo, L., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/1841527 · Cited by 37
Kjellström, B., Sandqvist, A., Hjalmarsson, C., Nisell, M., Näsman, P., & Ivarsson, B. (2020) · ERJ Open Research · doi:10.1183/23120541.00299-2020 · Cited by 37
Vanderpool, R. R., Hunter, K. S., Insel, M. B., Garcia, J. G. N., Bedrick, E. J., Tedford, R. J., & Rischard, F. P. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.09.040 · Cited by 37
Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis
Moutchia, J., McClelland, R. L., Al‐Naamani, N., Appleby, D. H., Holmes, J. H., Minhas, J., Mazurek, J. A., Palevsky, H. I., Ventetuolo, C. E., & Kawut, S. M. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae049 · Cited by 37
Treatment Discontinuation or Interruption in Pulmonary Arterial Hypertension
Narechania, S., Torbic, H., & Tonelli, A. R. (2019) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248419877409 · Cited by 36
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment
Attanasio, U., Cuomo, A., Pirozzi, F., Loffredo, S., Abete, P., Petretta, M., Marone, G., Bonaduce, D., de Paulis, A., Rossi, F. W., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124430 · Cited by 36
Role of the Immune System Elements in Pulmonary Arterial Hypertension
Tomaszewski, M., Bębnowska, D., Hrynkiewicz, R., Dworzyński, J., Niedźwiedzka‐Rystwej, P., Kopeć, G., & Grywalska, E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10163757 · Cited by 36
Pitre, T., Su, J. S., Cui, S., Scanlan, R., Chiang, C., Husnudinov, R., Khalid, M. F., Khan, N., Leung, G., Mikhail, D., et al. (2022) · European Respiratory Review · doi:10.1183/16000617.0036-2022 · Cited by 36
Brusca, S. B., Elinoff, J. M., Zou, Y., Jang, M. K., Kong, H., Demirkale, C. Y., Sun, J., Seifuddin, F., Pirooznia, M., Valantine, H. A., et al. (2022) · Circulation · doi:10.1161/circulationaha.121.056719 · Cited by 36
Self-citationInfluence of Body Weight and Diabetes Mellitus in Patients With Pulmonary Hypertension
Trammell, A. W., Hemnes, A. R., Tseng, V., Shah, A. J., Phillips, L. S., & Hart, C. M. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.07.062 · Cited by 36
Novel Advances in Modifying BMPR2 Signaling in PAH
Prosseda, S. D., Ali, M. K., & Spiekerkoetter, E. F. (2020) · Genes · doi:10.3390/genes12010008 · Cited by 35
Bernal‐Ramírez, J., Silva‐Platas, C., Jerjes-Sánchez, C., Ramos-González, M. R., Vázquez‐Garza, E., Chapoy‐Villanueva, H., Ramírez‐Rivera, A., Zarain‐Herzberg, Á., García, N., & García‐Rivas, G. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/9912434 · Cited by 35
Bernardo, R. J., Lu, D., Ramírez, R. L., Hedlin, H., Kawut, S. M., Bull, T., Marco, T. D., Ford, H. J., Grinnan, D., Klinger, J. R., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202109-1051oc · Cited by 34
Tang, S., Zeng, X., Liu, B., & Liu, B. (2022) · Scientific Reports · doi:10.1038/s41598-022-14307-6 · Cited by 34
Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension
Sherman, A. E., & Saggar, R. (2022) · Heart Failure Clinics · doi:10.1016/j.hfc.2022.08.015 · Cited by 34
Pulmonary arterial hypertension
Luna‐López, R., Martín, A. R., & Subías, P. E. (2022) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2022.05.010 · Cited by 33
The role of lactate metabolism and lactylation in pulmonary arterial hypertension
Peng, T.-Y., Lu, J., Zheng, X.-L., Zeng, C. C., & He, Y. (2025) · Respiratory Research · doi:10.1186/s12931-025-03163-3 · Cited by 32
Badagliacca, R., Rischard, F. P., Giudice, F. L., Howard, L., Papa, S., Valli, G., Manzi, G., Sciomer, S., Palange, P., Garcia, J. G. N., et al. (2022) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2022.02.021 · Cited by 32
Schneider, S., Mayer, L. C., Lichtblau, M., Berlier, C., Schwarz, E. I., Saxer, S., Tan, L., Furian, M., Bloch, K. E., & Ulrich, S. (2021) · ERJ Open Research · doi:10.1183/23120541.00314-2021 · Cited by 31
Lutsey, P. L., Prins, K. W., Evensen, L. H., Walker, R. F., Farley, J. F., MacLehose, R. F., Alonso, Á., Zakai, N. A., & Thenappan, T. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.024358 · Cited by 31
Khirfan, G., Almoushref, A., Naal, T., AbuHalimeh, B. J., Dweik, R. A., Heresi, G. A., & Tonelli, A. R. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.06.053 · Cited by 30
Chemocentric Informatics Analysis: Dexamethasone Versus Combination Therapy for COVID-19
Hajjo, R., Sabbah, D. A., & Bardaweel, S. K. (2020) · ACS Omega · doi:10.1021/acsomega.0c03597 · Cited by 30
Liu, P., Huang, W. R. H., Ding, Y., Wu, J., Liang, Z., Huang, Z., Xie, W., & Kong, H. (2021) · Drug Design Development and Therapy · doi:10.2147/dddt.s297500 · Cited by 30
Association of delayed diagnosis of pulmonary arterial hypertension with its prognosis
Kubota, K., Miyanaga, S., Akao, M., Mitsuyoshi, K., Iwatani, N., Higo, K., & Ohishi, M. (2023) · Journal of Cardiology · doi:10.1016/j.jjcc.2023.08.004 · Cited by 30
Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension
Yogeswaran, A., Richter, M. J., Sommer, N., Ghofrani, H. A., Seeger, W., Tello, K., & Gall, H. J. (2020) · Pulmonary Circulation · doi:10.1177/2045894020961739 · Cited by 29
Pulmonary arterial hypertension in systemic sclerosis
Lechartier, B., & Humbert, M. J. C. (2021) · La Presse Médicale · doi:10.1016/j.lpm.2021.104062 · Cited by 29
Benza, R. L., Ghofrani, H. A., Grünig, E., Hoeper, M. M., Jansa, P., Jing, Z., Kim, N. H., Langleben, D., Simonneau, G., Wang, C., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.06.020 · Cited by 29
Self-citationRemote 6-Minute-Walk Testing in Patients with Pulmonary Hypertension: A Pilot Study
Lapatra, T., Baird, G. L., Goodman, R., Pinder, D., Gaffney, M., Klinger, J. R., Palevsky, H. I., Fritz, J. S., Mullin, C. J., Mazurek, J. A., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202110-2421le · Cited by 29
Fitri, A. M. N., Elim, D., Mahfud, M. A. S., Sultan, N. A. F., Saputra, M. D., Afika, N., Friandini, R. A., Djide, N. J. N., & Permana, A. D. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122549 · Cited by 29
Imai, S., Sakao, S., Nagata, J., Naito, A., Sekine, A., Sugiura, T., Shigeta, A., Nishiyama, A., Yokota, H., Shimizu, N., et al. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-02891-4 · Cited by 29
Xanthouli, P., Kögler, M., Marra, A. M., Benjamin, N., Fischer, L., Eichstaedt, C. A., Harutyunova, S., Nagel, C., Grünig, E., & Egenlauf, B. (2020) · Respiratory Research · doi:10.1186/s12931-020-01393-1 · Cited by 29
Self-citationFarmakis, I. T., Demerouti, E., Karyofyllis, P., Karatasakis, G., Stratinaki, M., Tsiapras, D. P., Athanassopoulos, G. D., Voudris, V. V., & Giannakoulas, G. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132826 · Cited by 29
del Valle, K. T., & DuBrock, H. M. (2021) · Wiley eBooks · doi:10.1002/cphy.c210009 · Cited by 29
Ding, Y., Qian, J., Zhang, S., Xu, D., Leng, X., Zhao, J., Wang, Q., Zhang, W., Tian, X., Li, M., et al. (2022) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14368 · Cited by 28
Hansmann, G., Chouvarine, P., Diekmann, F., Giera, M. A., Ralser, M., Mülleder, M., von Kaisenberg, C., Bertram, H., Legchenko, E., & Hass, R. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00083-z · Cited by 28
Treatment of pediatric pulmonary arterial hypertension: A focus on the NO‐sGC‐cGMP pathway
Beghetti, M., Gorenflo, M., Ivy, D. D., Moledina, S., & Bonnet, D. (2019) · Pediatric Pulmonology · doi:10.1002/ppul.24442 · Cited by 28
Schweintzger, S., Köestenberger, M., Schlagenhauf, A., Grangl, G., Burmas, A., Kurath‐Koller, S., Pocivalnik, M., Sallmon, H., Baumgartner, D., Hansmann, G., et al. (2020) · Cardiovascular Diagnosis and Therapy · doi:10.21037/cdt.2020.04.01 · Cited by 28
Underfilling decreases left ventricular function in pulmonary arterial hypertension
Sjögren, H., Kjellström, B., Bredfelt, A., Steding‐Ehrenborg, K., Rådegran, G., Hesselstrand, R., Arheden, H., & Ostenfeld, E. (2021) · International journal of cardiac imaging · doi:10.1007/s10554-020-02143-6 · Cited by 27
DuBrock, H. M., Burger, C. D., Bartolome, S., Feldman, J. P., Ivy, D. D., Rosenzweig, E. B., Sager, J. S., Presberg, K. W., Mathai, S. C., Lammi, M. R., et al. (2021) · Pulmonary Circulation · doi:10.1177/20458940211020913 · Cited by 27
Self-citationHansmann, G., Diekmann, F., Chouvarine, P., Ius, F., Carlens, J., Schwerk, N., Warnecke, G., Vogel‐Claussen, J., Hohmann, D., Alten, T. A., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.10.014 · Cited by 27
Coursen, J. C., Simpson, C. E., Mukherjee, M., Vaught, A. “. J., Kutty, S., Al‐Talib, T. K., Wood, M. J., Scott, N. S., Mathai, S. C., & Sharma, G. V. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9080260 · Cited by 27
Pulmonary Hypertension in Women
Park, E., & Safdar, Z. (2024) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/mdcvj.1308 · Cited by 27
Self-citationBlood carbon dioxide tension and risk in pulmonary arterial hypertension
Harbaum, L., Fuge, J., Kamp, J. C., Hennigs, J. K., Simon, M., Sinning, C., Oqueka, T., Grimminger, J., Olsson, K. M., Hoeper, M. M., et al. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.06.069 · Cited by 27
Novel Treatment Pathways in Pulmonary Arterial Hypertension
Qaiser, K. N., & Tonelli, A. R. (2021) · Methodist DeBakey Cardiovascular Journal · doi:10.14797/cbhs2234 · Cited by 26
A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension
CASCINO, T. M., Sahay, S., Moles, V., & McLaughlin, V. V. (2024) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2024.09.021 · Cited by 26
Self-citationHeart Rate Reduction Improves Right Ventricular Function and Fibrosis in Pulmonary Hypertension
Ishii, R., Okumura, K., Akazawa, Y., Malhi, M., Ebata, R., Sun, M., Fujioka, T., Kato, H., Honjo, O., Kabir, G., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0317oc · Cited by 26
Sitbon, O., Nikkho, S. M., Benza, R. L., Deng, C. Q., Farber, H. W., Gomberg‐Maitland, M., Hassoun, P. M., Meier, C., Pepke‐Żaba, J., Prasad, K., et al. (2020) · Pulmonary Circulation · doi:10.1177/2045894020962960 · Cited by 26
Kim, N. H., Hemnes, A. R., Chakinala, M. M., Highland, K. B., Chin, K., McLaughlin, V. V., Zhao, C., NARAYAN, V., & Farber, H. W. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.01.006 · Cited by 26
Self-citationValentin, S., Maurac, A., Sitbon, O., Beurnier, A., Gomez, E., Guillaumot, A., Textoris, L., Fay, R., Savale, L., Jaïs, X., et al. (2021) · European Respiratory Journal · doi:10.1183/13993003.04066-2020 · Cited by 25
Alves-Silva, J. M., Zuzarte, M., Marques, C., Viana, S., Preguiça, I., Baptista, R., Ferreira, C., Cavaleiro, C., Domingues, N. S., Sardão, V. A., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2022.106151 · Cited by 25
Shi, B., Zhou, T., Lv, S., Wang, M., Chen, S., Heidari, A. A., Huang, X., Chen, H., Wang, L., & Wu, P. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105529 · Cited by 25
Pizzicato, L. N., Nadipelli, V. R., Governor, S., Mao, J., Lanes, S., Butler, J., Pepe, R. S., Phatak, H. M., & El‐Kersh, K. (2022) · Pulmonary Circulation · doi:10.1002/pul2.12090 · Cited by 25
The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension
Haddad, F., Contrepois, K., Amsallem, M., Denault, A. Y., Bernardo, R. J., Jha, A., Taylor, S., Ataam, J. A., Mercier, O. M., Kuznetsova, T., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.10.045 · Cited by 25
Treating Inflammation Associated with Pulmonary Hypertension: An Overview of the Literature
Yoo, H. H. B., & Marin, F. L. (2022) · International Journal of General Medicine · doi:10.2147/ijgm.s295463 · Cited by 25
Simons, J. E., Mann, E. B., & Pierozynski, A. (2019) · Advances in Therapy · doi:10.1007/s12325-019-01030-4 · Cited by 25
Saleh, D., Fisher, J. H., Provencher, S., Liang, Z., Ryerson, C. J., & Weatherald, J. C. (2021) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202103-325oc · Cited by 24
Sahay, S., Bhatt, J., Beshay, S. M., Guha, A., Nguyen, D. T., Graviss, E. A., & Nagueh, S. F. (2021) · Pulmonary Circulation · doi:10.1002/pul2.12026 · Cited by 24
Certain, M. C., Baron, A., Turpin, M., Ebstein, N., Boucly, A., Beurnier, A., Jevnikar, M., Roche, A., Keddache, S., Bulifon, S., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.00107-2022 · Cited by 24
Cajigas, H. R., Burger, C. D., Cartin‐Ceba, R., DuBrock, H. M., Swanson, K. L., Vargas, H. E., Keaveny, A. P., Watt, K. D. S., & Krowka, M. J. (2022) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2022.08.020 · Cited by 24
Coghlan, G., Gaine, S., Channick, R. N., Chin, K., Roure, C. D., Gibbs, J. S. R., Hoeper, M. M., Lang, I. M., Mathai, S. C., McLaughlin, V. V., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00456-2022 · Cited by 24
Self-citationMcLaughlin, V. V., Alsumali, A., Liu, R., Klok, R. M., Martinez, E. C., Nourhussein, I., Bernotas, D., Chevure, J., Pausch, C., Pena, J. D. O., et al. (2023) · Advances in Therapy · doi:10.1007/s12325-023-02684-x · Cited by 24
Self-citationPulmonary Hypertension Associated with Connective Tissue Disease
Mathai, S. C. (2021) · Cardiology Clinics · doi:10.1016/j.ccl.2021.08.003 · Cited by 24
Wronski, S. L., Mordin, M., Kelley, K., Anguiano, R. H., Classi, P. M., Shen, E., & Manaker, S. (2019) · Lung · doi:10.1007/s00408-019-00289-2 · Cited by 24
Richter, M. J., Zedler, D., Berliner, D., Douschan, P., Gall, H. J., Ghofrani, H. A., Kimmig, L. M., Kremer, N., Olsson, K. M., da Rocha, B. R. B., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.775039 · Cited by 23
Relevance of comorbidities on initial combination therapy in pulmonary arterial hypertension
Badagliacca, R., D’Alto, M., Ghio, S., Argiento, P., Brunetti, N. D., Casu, G., Cedrone, N., Confalonieri, M., Corda, M., Correale, M., et al. (2022) · ERJ Open Research · doi:10.1183/23120541.00298-2022 · Cited by 23
Qin, Y., Yan, G., Qiao, Y., Wang, D., & Tang, C. (2023) · BMC Genomics · doi:10.1186/s12864-023-09892-3 · Cited by 23
Small, M., Perchenet, L., Bennett, A., & Linder, J. (2024) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666231218886 · Cited by 23
Wilson, M. A., Keeley, J. H., Kingman, M. S., Wang, J., & Rogers, F. (2020) · Pulmonary Circulation · doi:10.1177/2045894020950186 · Cited by 23
Miotti, C., Papa, S., Manzi, G., Scoccia, G., Luongo, F., Toto, F., Malerba, C., Cedrone, N., Sciomer, S., Ciciarello, F., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040619 · Cited by 23
Brugger, N., Lichtblau, M., Maeder, M. T., Müller, H., Pellaton, C., Yerly, P., & Swiss Society For Pulmonary Hypertension Ssph (2021) · Swiss Medical Weekly · doi:10.4414/smw.2021.20486 · Cited by 23
Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs
Jin, Q., Chen, D., Zhang, X., Zhang, F., Zhong, D., Lin, D., Guan, L., Pan, W., Zhou, D., & Ge, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15061579 · Cited by 22
Management of Pulmonary Arterial Hypertension: Current Strategies and Future Prospects
Sharma, M., Paudyal, V., Syed, S., Thapa, R., Kassam, N., & Surani, S. (2025) · Life · doi:10.3390/life15030430 · Cited by 22
Yanaka, K., Guillien, A., Soumagne, T., Bénet, J., Piliero, N., Picard, F., Pison, C. M., Sitbon, O., Bouvaist, H., & Degano, B. (2020) · European Respiratory Journal · doi:10.1183/13993003.02418-2019 · Cited by 22
Reducing economic burden and improving quality of life in pulmonary arterial hypertension
Burgoyne, D. S. (2021) · The American Journal of Managed Care · doi:10.37765/ajmc.2021.88611 · Cited by 21
Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension
Rossi, R., Talarico, M., Schepis, F., Coppi, F., Sgura, F. A., Monopoli, D. E., Minici, R., & Boriani, G. (2021) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2021.102071 · Cited by 21
Inhaled Iloprost Improves Right Ventricular Load–Independent Contractility in Pulmonary Hypertension
Tello, K., Kremer, N., Richter, M. J., Gall, H. J., Münks, J., Ghofrani, H. A., SCHERMULY, R. T., Naeije, R., Kojonazarov, B. K., & Seeger, W. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202201-0095le · Cited by 21
Sugiyama, Y., Matsubara, H., Shimokawahara, H., & Ogawa, A. (2022) · Journal of Cardiology · doi:10.1016/j.jjcc.2022.04.003 · Cited by 21
Badagliacca, R., Vizza, C. D., Lang, I. M., Sadushi‐Kolici, R., Papa, S., Manzi, G., Filomena, D., Ogawa, A., Shimokawahara, H., & Matsubara, H. (2022) · Vascular Pharmacology · doi:10.1016/j.vph.2022.107099 · Cited by 21
Pulmonary vascular disease as a complication of pediatric congenital heart diseases
Wacker, J., Joye, R., Genecand, L., Lador, F., & Beghetti, M. (2023) · Translational Pediatrics · doi:10.21037/tp-23-64 · Cited by 21
Beyond VO2: the complex cardiopulmonary exercise test
Mattavelli, I., Vignati, C., Farina, S., Apostolo, A., Cattadori, G., Martino, F. D., Pezzuto, B., Zaffalon, D., & Agostoni, P. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad154 · Cited by 21
Metadata
- Authors
- Galiè, N., Channick, R. N., Frantz, R. P., Grünig, E., Jing, Z. C., Moiseeva, O., Preston, I. R., Pulido, T., Safdar, Z., Tamura, Y., & McLaughlin, V. V.
- Affiliations
- University of Bologna (IT)
- Harvard University (US)
- Mayo Clinic (US)
- University Hospital Heidelberg (DE)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Tufts University (US)
- Houston Methodist (US)
- International University of Health and Welfare (JP)
- University of Michigan (US)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801889
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351343
- OpenAlex
- W2904385559
- Cited by
- 819
- References
- 88
- Citations by year
- 2026: 32 · 2025: 46 · 2024: 101 · 2023: 108 · 2022: 174 · 2021: 169 · 2020: 128 · 2019: 58
- FWCI
- 15.86
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
- Funders
- Japan Society for the Promotion of Science (18K08183)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- pulmonary arterial hypertension, risk stratification, medical therapy, combination therapy, treatment escalation, endothelin receptor antagonists, phosphodiesterase-5 inhibitors, prostacyclin analogues, right ventricular function, exercise capacity, one-year mortality, lung transplantation, treatment algorithm
- MeSH terms
- Pulmonary Arterial Hypertension, Calcium Channel Blockers, Humans, Randomized Controlled Trials as Topic, Lung Transplantation, Practice Guidelines as Topic, Risk Assessment, Phosphodiesterase 5 Inhibitors, Endothelin Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.